News Details
|
biolitec has entered into a non-binding letter of intent for the acquisition of specified assets of Diomed Holdings, Inc. 3/14/2008 ena, March 14, 2008 – biolitec AG, Jena, listed in the Prime Standard of the Frankfurt stock exchange (ISIN DE0005213409), has entered into a non-binding letter of intent for the acquisition of certain operating assets of Diomed Holdings, Inc., (AMEX:DIO), a leading developer and marketer of minimally invasive medical technologies including laser treatment for varicose veins in the USA. The senior management of both companies anticipate a purchase price of between $6 and $7 million for these assets. biolitec expects to complete the asset purchase within approximately 2 to 3 months. Diomed reported revenues of $ 26 million in the fiscal year ended December 31, 2007. After a restructuring phase biolitec expects strong synergies due to this purchase mainly for the vein business as well as an expansion of its own market position in the field of minimal invasive technologies in the USA. Back to News List |
 |
 |
lasers/fibers  biolitec cutting edge medical lasers systems and fibers can benefit your patients and practice. Learn how |
 |
 |
 |
 |
 |
| In-Office BPH Treatment Vein Treatment  More doctors are choosing EVOLVE SLV™ and ELVeS™ to provide these in-office treatments. We can help you locate a doctor near you. |
 |
 |
 |
|
|
resources SUBSCRIBE TO E-NEWSLETTER  SEMINARSbiolitec provides free laser education by specialty for all of our laser owners and others. Learn More  NEWSAs a leading developer in the field of medical laser treatment and technology biolitec is always on the cutting edge. Read now |
|
|
|
 |
 |
| Request a Quote Save more of your income by spending less on your disposables. Enjoy low prices you can only get directly from the manufacturer. Learn how |
 |
 |
 |